1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CORCEPT THERAPEUTICS INC
Corcept Therapeutics Inc
XNAS: CORT
110.29 -4.57 (-3.98%)
17.2M

XNAS 18 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Corcept Therapeutics Inc - CORT - stock price prediction, stock price target, analyst ratings from 5 analysts

Corcept Therapeutics Inc has a share price target of US$ 141, revenue growth forecast of 50.5%, and profit growth estimate of 146.0% for FY26, based on top 5 analyst calls.